An N Massaro1,2, Jennifer K Lee3, Gilbert Vezina4,5, Penny Glass6,5, Alexandra O'Kane7, Ruoying Li7, Taeun Chang7,5, Kenneth Brady8, Rathinaswamy Govindan9,5. 1. Division of Neonatology, Children's National Hospital, Washington, DC, USA. anguyenm@childrensnational.org. 2. The George Washington University School of Medicine, Washington, DC, USA. anguyenm@childrensnational.org. 3. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Diagnostic Imaging and Radiology, Children's National Hospital, Washington, DC, USA. 5. The George Washington University School of Medicine, Washington, DC, USA. 6. Psychology and Behavioral Health, Children's National Hospital, Washington, DC, USA. 7. Neurology, Children's National Hospital, Washington, DC, USA. 8. Department of Anesthesia, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 9. Fetal and Transitional Medicine, Children's National Hospital, Washington, DC, USA.
Abstract
BACKGROUND/ OBJECTIVE: Near-infrared spectroscopy (NIRS)-based measures of cerebral autoregulation (CAR) can potentially identify neonates with hypoxic-ischemic encephalopathy (HIE) who are at greatest risk of irreversible brain injury. However, modest predictive abilities have precluded previously described metrics from entering clinical care. We previously validated a novel autoregulation metric in a piglet model of induced hypotension called the hemoglobin volume phase index (HVP). The objective of this study was to evaluate the clinical ability of the HVP to predict adverse outcomes neonates with HIE. METHODS: This is a prospective study of neonates with HIE who underwent therapeutic hypothermia (TH) at a level 4 neonatal intensive care unit (NICU). Continuous cerebral NIRS and mean arterial blood pressure (MAP) from indwelling arterial catheters were measured during TH and through rewarming. Multivariate autoregressive process was used to calculate the coherence between MAP and the sum total of the oxy- and deoxygenated Hb densities (HbT), a surrogate measure of cerebral blood volume (CBV). The HVP was calculated as the cosine-transformed phase shift at the frequency of maximal MAP-HbT coherence. Brain injury was assessed by neonatal magnetic resonance imaging (MRI), and developmental outcomes were assessed by the Bayley Scales of Infant Development (BSID-III) at 15-30 months. The ability of the HVP to predict (a) death or severe brain injury by MRI and (b) death or significant developmental delay was assessed using logistic regression analyses. RESULTS: In total, 50 neonates with moderate or severe HIE were monitored. Median HVP was higher, representing more dysfunctional autoregulation, in infants who had adverse outcomes. After adjusting for sex and encephalopathy grade at presentation, HVP at 21-24 and 24-27 h of life predicted death or brain injury by MRI (21-24 h: OR 8.8, p = 0.037; 24-27 h: OR 31, p = 0.011) and death or developmental delay at 15-30 months (21-24 h: OR 11.8, p = 0.05; 24-27 h: OR 15, p = 0.035). CONCLUSIONS: Based on this pilot study of neonates with HIE, HVP merits further study as an indicator of death or severe brain injury on neonatal MRI and neurodevelopmental delay in early childhood. Larger studies are warranted for further clinical validation of the HVP to evaluate cerebral autoregulation following HIE.
BACKGROUND/ OBJECTIVE: Near-infrared spectroscopy (NIRS)-based measures of cerebral autoregulation (CAR) can potentially identify neonates with hypoxic-ischemic encephalopathy (HIE) who are at greatest risk of irreversible brain injury. However, modest predictive abilities have precluded previously described metrics from entering clinical care. We previously validated a novel autoregulation metric in a piglet model of induced hypotension called the hemoglobin volume phase index (HVP). The objective of this study was to evaluate the clinical ability of the HVP to predict adverse outcomes neonates with HIE. METHODS: This is a prospective study of neonates with HIE who underwent therapeutic hypothermia (TH) at a level 4 neonatal intensive care unit (NICU). Continuous cerebral NIRS and mean arterial blood pressure (MAP) from indwelling arterial catheters were measured during TH and through rewarming. Multivariate autoregressive process was used to calculate the coherence between MAP and the sum total of the oxy- and deoxygenated Hb densities (HbT), a surrogate measure of cerebral blood volume (CBV). The HVP was calculated as the cosine-transformed phase shift at the frequency of maximal MAP-HbT coherence. Brain injury was assessed by neonatal magnetic resonance imaging (MRI), and developmental outcomes were assessed by the Bayley Scales of Infant Development (BSID-III) at 15-30 months. The ability of the HVP to predict (a) death or severe brain injury by MRI and (b) death or significant developmental delay was assessed using logistic regression analyses. RESULTS: In total, 50 neonates with moderate or severe HIE were monitored. Median HVP was higher, representing more dysfunctional autoregulation, in infants who had adverse outcomes. After adjusting for sex and encephalopathy grade at presentation, HVP at 21-24 and 24-27 h of life predicted death or brain injury by MRI (21-24 h: OR 8.8, p = 0.037; 24-27 h: OR 31, p = 0.011) and death or developmental delay at 15-30 months (21-24 h: OR 11.8, p = 0.05; 24-27 h: OR 15, p = 0.035). CONCLUSIONS: Based on this pilot study of neonates with HIE, HVP merits further study as an indicator of death or severe brain injury on neonatal MRI and neurodevelopmental delay in early childhood. Larger studies are warranted for further clinical validation of the HVP to evaluate cerebral autoregulation following HIE.
Authors: Seetha Shankaran; Athina Pappas; Scott A McDonald; Betty R Vohr; Susan R Hintz; Kimberly Yolton; Kathryn E Gustafson; Theresa M Leach; Charles Green; Rebecca Bara; Carolyn M Petrie Huitema; Richard A Ehrenkranz; Jon E Tyson; Abhik Das; Jane Hammond; Myriam Peralta-Carcelen; Patricia W Evans; Roy J Heyne; Deanne E Wilson-Costello; Yvonne E Vaucher; Charles R Bauer; Anna M Dusick; Ira Adams-Chapman; Ricki F Goldstein; Ronnie Guillet; Lu-Ann Papile; Rosemary D Higgins Journal: N Engl J Med Date: 2012-05-31 Impact factor: 91.245
Authors: Susan E Jacobs; Colin J Morley; Terrie E Inder; Michael J Stewart; Katherine R Smith; Patrick J McNamara; Ian M R Wright; Haresh M Kirpalani; Brian A Darlow; Lex W Doyle Journal: Arch Pediatr Adolesc Med Date: 2011-04-04
Authors: Seetha Shankaran; Abbot R Laptook; Richard A Ehrenkranz; Jon E Tyson; Scott A McDonald; Edward F Donovan; Avroy A Fanaroff; W Kenneth Poole; Linda L Wright; Rosemary D Higgins; Neil N Finer; Waldemar A Carlo; Shahnaz Duara; William Oh; C Michael Cotten; David K Stevenson; Barbara J Stoll; James A Lemons; Ronnie Guillet; Alan H Jobe Journal: N Engl J Med Date: 2005-10-13 Impact factor: 91.245
Authors: Denis V Azzopardi; Brenda Strohm; A David Edwards; Leigh Dyet; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Neil Marlow; Emma Porter; Marianne Thoresen; Andrew Whitelaw; Peter Brocklehurst Journal: N Engl J Med Date: 2009-10-01 Impact factor: 91.245
Authors: Peter D Gluckman; John S Wyatt; Denis Azzopardi; Roberta Ballard; A David Edwards; Donna M Ferriero; Richard A Polin; Charlene M Robertson; Marianne Thoresen; Andrew Whitelaw; Alistair J Gunn Journal: Lancet Date: 2005 Feb 19-25 Impact factor: 79.321
Authors: Denis Azzopardi; Brenda Strohm; Neil Marlow; Peter Brocklehurst; Aniko Deierl; Oya Eddama; Julia Goodwin; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Louise Linsell; Omar Omar; Marianne Thoresen; Nora Tusor; Andrew Whitelaw; A David Edwards Journal: N Engl J Med Date: 2014-07-10 Impact factor: 91.245
Authors: Xiuyun Liu; Aylin Tekes; Jamie Perin; May W Chen; Bruno P Soares; An N Massaro; Rathinaswamy B Govindan; Charlamaine Parkinson; Raul Chavez-Valdez; Frances J Northington; Ken M Brady; Jennifer K Lee Journal: Front Neurol Date: 2021-04-28 Impact factor: 4.003
Authors: Rachel L Leon; Eric B Ortigoza; Noorjahan Ali; Dimitrios Angelis; Joshua S Wolovits; Lina F Chalak Journal: Front Pediatr Date: 2022-01-11 Impact factor: 3.418